MX2023003993A - Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina. - Google Patents
Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina.Info
- Publication number
- MX2023003993A MX2023003993A MX2023003993A MX2023003993A MX2023003993A MX 2023003993 A MX2023003993 A MX 2023003993A MX 2023003993 A MX2023003993 A MX 2023003993A MX 2023003993 A MX2023003993 A MX 2023003993A MX 2023003993 A MX2023003993 A MX 2023003993A
- Authority
- MX
- Mexico
- Prior art keywords
- psychosis
- bipolar disorders
- treatment
- dexmedetomidine hydrochloride
- methods
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title abstract 3
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 229960002746 dexmedetomidine hydrochloride Drugs 0.000 title 1
- VPNGEIHDPSLNMU-MERQFXBCSA-N dexmedetomidine hydrochloride Chemical compound Cl.C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CNC=N1 VPNGEIHDPSLNMU-MERQFXBCSA-N 0.000 title 1
- 206010026749 Mania Diseases 0.000 abstract 2
- 206010021030 Hypomania Diseases 0.000 abstract 1
- HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 abstract 1
- 229960004253 dexmedetomidine Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089135P | 2020-10-08 | 2020-10-08 | |
| PCT/US2021/054171 WO2022076818A1 (en) | 2020-10-08 | 2021-10-08 | Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023003993A true MX2023003993A (es) | 2023-05-24 |
Family
ID=81126063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023003993A MX2023003993A (es) | 2020-10-08 | 2021-10-08 | Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240024289A1 (https=) |
| EP (1) | EP4225305A4 (https=) |
| JP (1) | JP2023545372A (https=) |
| KR (1) | KR20230084186A (https=) |
| CN (1) | CN116615243A (https=) |
| AU (1) | AU2021356687A1 (https=) |
| CA (1) | CA3195133A1 (https=) |
| IL (1) | IL301971A (https=) |
| MX (1) | MX2023003993A (https=) |
| TW (1) | TW202228682A (https=) |
| WO (1) | WO2022076818A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102793584B1 (ko) | 2016-12-31 | 2025-04-09 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 불안의 치료를 위한 설하 덱스메데토미딘의 용도 |
| PL3813802T3 (pl) | 2018-06-27 | 2025-04-22 | Bioxcel Therapeutics, Inc. | Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania |
| EP3999058A4 (en) | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| DK2906213T3 (en) * | 2012-10-15 | 2018-02-19 | Orion Corp | VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY |
| CA2924190C (en) * | 2013-10-07 | 2019-07-09 | Teikoku Pharma Usa, Inc. | Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions |
| KR102793584B1 (ko) * | 2016-12-31 | 2025-04-09 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 불안의 치료를 위한 설하 덱스메데토미딘의 용도 |
| EP3999058A4 (en) * | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN |
-
2021
- 2021-10-08 EP EP21878615.0A patent/EP4225305A4/en not_active Withdrawn
- 2021-10-08 WO PCT/US2021/054171 patent/WO2022076818A1/en not_active Ceased
- 2021-10-08 CN CN202180069020.2A patent/CN116615243A/zh active Pending
- 2021-10-08 KR KR1020237013556A patent/KR20230084186A/ko not_active Withdrawn
- 2021-10-08 CA CA3195133A patent/CA3195133A1/en active Pending
- 2021-10-08 MX MX2023003993A patent/MX2023003993A/es unknown
- 2021-10-08 IL IL301971A patent/IL301971A/en unknown
- 2021-10-08 US US18/030,405 patent/US20240024289A1/en active Pending
- 2021-10-08 JP JP2023518752A patent/JP2023545372A/ja active Pending
- 2021-10-08 AU AU2021356687A patent/AU2021356687A1/en not_active Abandoned
- 2021-10-08 TW TW110137597A patent/TW202228682A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023545372A (ja) | 2023-10-30 |
| EP4225305A4 (en) | 2024-10-23 |
| AU2021356687A1 (en) | 2023-06-15 |
| CA3195133A1 (en) | 2022-04-14 |
| WO2022076818A1 (en) | 2022-04-14 |
| KR20230084186A (ko) | 2023-06-12 |
| EP4225305A1 (en) | 2023-08-16 |
| CN116615243A (zh) | 2023-08-18 |
| AU2021356687A9 (en) | 2024-10-03 |
| IL301971A (en) | 2023-06-01 |
| TW202228682A (zh) | 2022-08-01 |
| US20240024289A1 (en) | 2024-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023003993A (es) | Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina. | |
| MX2021010058A (es) | Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel. | |
| MX2020008680A (es) | Terapia de combinacion con apilimod y agentes glutamatergicos. | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| MX2009013989A (es) | Terapia en combinacion para depresion. | |
| MX2019009227A (es) | Métodos para tratar cáncer con inhibidores de hsp90. | |
| MY199903A (en) | Combination therapy with controlled-release cnp agonists | |
| ZA202304965B (en) | Combination therapy for treating cancer | |
| MX2024000049A (es) | Degradador de tirosina cinasa y mutante de bruton, composicion y aplicacion del mismo. | |
| MY199382A (en) | Methods of treating circadian rhythm sleep disorders | |
| BR112023002458A2 (pt) | Métodos de tratamento da gota | |
| MX2024013613A (es) | Anticuerpos il-13 para el tratamiento de la dermatitis atopica | |
| MX2021002349A (es) | Inhibidores de calicreína en plasmá y usos de los mismos para tratar ataque de angioedema hereditario. | |
| BR112023018944A2 (pt) | Composição de terapia gênica e tratamento de cardiomiopatia arritmogênica ventricular direita | |
| MX2021004207A (es) | Uso de reboxetina para el tratamiento de narcolepsia. | |
| MX2024001954A (es) | Anticuerpos il-13 para el tratamiento de la dermatitis atopica. | |
| MX2023010711A (es) | Fenalquilaminas y métodos de preparación y uso de las mismas. | |
| MX2025001920A (es) | Tratamiento de enfermedades y trastornos asociados a las mitocondrias, incluyendo los sintomas de los mismos usando pridopidina | |
| MX2018010223A (es) | Terapia combinada para tratamiento de cancer de ovario. | |
| JOP20220168A1 (ar) | طرق علاج الطحال | |
| MX2023006551A (es) | Tratamiento de las convulsiones refractarias. | |
| MX2023015097A (es) | Tratamiento de sintomas asociados a neoplasias mieloproliferativas. | |
| PH12022551371A1 (en) | Macrocycles for use in treating disease | |
| EP4623999A3 (en) | Sotorasib for use in the treatment of cancer | |
| MX2020008881A (es) | Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1. |